UC San Francisco’s Lydia Zablotska, MD, PhD, grew up in Ukraine, trained as physician in Belarus, and has studied the long-term health impacts of radiation exposure on the Chernobyl cleanup workers, local children and others in the region. Her research helped uncover the connection between radiation exposure, thyroid conditions and leukemia, and remains relevant to global health today.

Steven Pantilat, MD ’89, is chief of UC San Francisco’s new Division of Palliative Medicine, an international expert in the field, and a lover of poetry that speaks to the heart. A line from a Mary Oliver poem inspires his work: “Tell me, what is ...

Using advanced technology, scientists at Chan Zuckerberg (CZ) Biohub, Mayo Clinic and UC San Francisco, have discovered an autoimmune disease that appears to affect men with testicular cancer. Called “testicular cancer-associated paraneoplastic encephalitis,” the disease causes severe neurological symptoms in men. They progressively lose control ...

The new watchword for the frontlines of cancer treatment is “precision.” Whether here at the University of California, San Francisco or other leading centers around the world, the field’s best minds are probing more deeply than ever into the cellular and molecular underpinnings of cancer, and working to harness vast amounts of new data to revolutionize everything from diagnosis to the most effective drugs and the costs of care.

UC San Francisco is opening a pioneering cancer center devoted to providing adult patients with highly advanced treatments, including immunotherapy, genetic counseling, molecular profiling of tumors, fully integrated clinical trials, and advanced imaging.